VIRBAC
Location
PROVENCE ALPES COTE D AZUR
Founded
1984-04-01
Website
Risk Signals
1568 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about VIRBAC
Live alerts from global media, monitored by Business Radar
2025-08-11 (boursier.com)
Virbac gives up 0.75%
(Boursier.com) - Action Virbac finished down slightly on the Paris Stock Exchange. A drop of 0.75%, the share which finished at € 329,000 against € 331,500 at the end on Friday.
Read more
2025-07-03 (abcbourse.com)
Virbac leaps on the stock market after a note from Oddo BHF which targets 395 euros
Virbac did not meow this morning when the scholarship was opened, it rugged. The animal health specialist flies away
Read more
2025-06-16 (boursier.com)
Virbac drops 0.94%
(Boursier.com) - Action Virbac finished down slightly on the Paris Stock Exchange. A drop of 0.94%, the share which ended at € 315,000 against € 318,000 at the end on Friday.
Read more
2025-02-11 (openpr.com)
Veterinary Infectious Diseases Therapeutics Market Share and Competitive Dynamics: Zoetis, Merck, Boehringer Ingelheim, Elanco, Virbac
Press release - Orion Market Research - Veterinary Infectious Diseases Therapeutics Market Share and Competitive Dynamics: Zoetis, Merck, Boehringer Ingelheim, Elanco, Virbac - published on openPR.com
Read more
2025-02-07 (boursier.com)
Virbac gives up 0.95%
(Boursier.com) - The Virbac title had a difficult day on the Paris Stock Exchange. The value recorded a slight drop of 0.95% to end at € 313.50.
Read more
2025-01-18 (lerevenu.com)
Virbac: activity has progressed but visibility remains fragile -
Although activity proved to be very dynamic during the past financial year, the company is no longer trading on the stock market. Because the visibility is not that good.
Read more
2025-01-18 (lerevenu.com)
Virbac: activity has progressed but visibility remains fragile -
Although activity proved to be very dynamic during the past financial year, the company is no longer trading on the stock market. Because the visibility is not that good.
Read more
2025-01-17 (boursier.com)
Virbac drops 2.99%
(Boursier.com) — Virbac shares had a difficult day on the Paris Stock Exchange. The value recorded a sharp drop of 2.99% to close at €308.00.
Read more
2025-01-17 (abcbourse.com)
Virbac: TP Icap Midcap lowers its price target
TP Icap Midcap remains Buy on Virbac but lowers its price target from 420 to 390 euros after the publication of annual revenues. The office
Read more
2025-01-17 (abcbourse.com)
Virbac: TP Icap Midcap lowers its price target
TP Icap Midcap remains Buy on Virbac but lowers its price target from 420 to 390 euros after the publication of annual revenues. The office
Read more
2025-01-17 (abcbourse.com)
Virbac: TP Icap Midcap lowers its price target
TP Icap Midcap remains Buy on Virbac but lowers its price target from 420 to 390 euros after the publication of annual revenues. The office
Read more
2024-12-20 (boursier.com)
Virbac ends slightly down
(Boursier.com) — Virbac shares ended slightly lower on the Paris Stock Exchange. A drop of 0.80%, the share having ended at €309.50 against €312.00 at the close the day before.
Read more